BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,511 | -1.5% | 6,852 | -2.0% | 0.00% | – |
| Q2 2023 | $49,238 | -11.7% | 6,994 | +4.7% | 0.00% | -100.0% |
| Q1 2023 | $55,736 | -12.4% | 6,683 | +20.6% | 0.00% | 0.0% |
| Q4 2022 | $63,634 | -9.1% | 5,543 | -0.7% | 0.00% | 0.0% |
| Q3 2022 | $70,000 | +45.8% | 5,582 | +24.0% | 0.00% | 0.0% |
| Q2 2022 | $48,000 | -34.2% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $73,000 | +17.7% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $62,000 | -4.6% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $65,000 | -8.5% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $71,000 | +54.3% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $46,000 | +35.3% | 4,501 | 0.0% | 0.00% | – |
| Q4 2020 | $34,000 | +126.7% | 4,501 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | -28.6% | 4,501 | 0.0% | 0.00% | – |
| Q2 2020 | $21,000 | +133.3% | 4,501 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | -43.8% | 4,501 | 0.0% | 0.00% | – |
| Q4 2019 | $16,000 | +23.1% | 4,501 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | -23.5% | 4,501 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | -54.1% | 4,501 | +0.0% | 0.00% | -100.0% |
| Q1 2019 | $37,000 | +2.8% | 4,500 | -0.0% | 0.00% | 0.0% |
| Q4 2018 | $36,000 | +5.9% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $34,000 | +30.8% | 4,501 | +0.0% | 0.00% | – |
| Q2 2018 | $26,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |